EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C24H34F3N3O3 |
| Net Charge | 0 |
| Average Mass | 469.548 |
| Monoisotopic Mass | 469.25523 |
| SMILES | CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)(C(C)C)C1 |
| InChI | InChI=1S/C24H34F3N3O3/c1-15(2)23(7-4-18(11-23)29-20-6-9-33-14-21(20)32-3)22(31)30-8-5-19-16(13-30)10-17(12-28-19)24(25,26)27/h10,12,15,18,20-21,29H,4-9,11,13-14H2,1-3H3/t18-,20+,21-,23+/m1/s1 |
| InChIKey | MTMDXAIUENDNDL-RJSMDTJLSA-N |
| Roles Classification |
|---|
| Biological Role: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. |
| Applications: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. antirheumatic drug A drug used to treat rheumatoid arthritis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| mk-0812 (CHEBI:755313) has functional parent δ-amino acid (CHEBI:35931) |
| mk-0812 (CHEBI:755313) has role antirheumatic drug (CHEBI:35842) |
| mk-0812 (CHEBI:755313) has role immunosuppressive agent (CHEBI:35705) |
| mk-0812 (CHEBI:755313) is a organonitrogen compound (CHEBI:35352) |
| mk-0812 (CHEBI:755313) is a organooxygen compound (CHEBI:36963) |
| Synonyms | Source |
|---|---|
| Mk-0812 | ChEMBL |
| Mk0812 | ChEMBL |
| Citations |
|---|